Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...

A GRAN who shed more than five stone on Mounjaro is now fundraising to have surgery abroad – as she compares her saggy skin ...

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

A weight-loss trial of the two drugs found one clear winner. In case you’re not totally clued up, Wegovy is just a different ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...

Eventually, it was proven that Mounjaro is more affective than Wegovy in terms of weight loss, with 32 per cent of ...

Ozempic and Mounjaro, originally diabetes medications, have exploded in popularity as powerful weight-loss injectables.

A leading obesity doctor has said a new trial of weight loss drugs Mounjaro and Wegovy may lead advertisers to reconsider their prices. Professor Naveed Sattar, an honorary consultant in ...

Shivaji Dasgupta, an autonomous Brand Consultant, writes that India’s obsession with shortcuts risks turning a breakthrough ...

The Royal College of GPs’ weight loss expert has sounded a warning bell for users of popular drugs Ozempic, Mounjaro and ...